KLOW Stack
Protocol Guide
The KLOW Stack is a metabolic research protocol combining complementary compounds to study synergistic effects on appetite regulation, glucose metabolism, and body composition. It represents a multi-mechanism approach to metabolic research that mirrors the combination therapy direction of pharmaceutical development.
What is KLOW Stack?
KLOW is a pre-blended 80 mg vial combining four tissue-repair and anti-inflammatory peptides: GHK-Cu (50 mg), TB-500 (10 mg), BPC-157 (10 mg), and KPV (10 mg). Each component addresses a distinct pathway in healing and regeneration — collagen synthesis, cell migration, localised repair, and NF-κB-mediated inflammation control — making KLOW a comprehensive multi-mechanism protocol in a single daily injection.
By combining all four in a single pre-blended vial, KLOW delivers synergistic action across regenerative (GHK-Cu + TB-500 + BPC-157) and anti-inflammatory (KPV + BPC-157) pathways — a simpler approach than managing four separate compounds. Reconstitute with 3.0 mL BAC water for a total concentration of ~26.7 mg/mL
Dosing Schedule
Parameters documented in published preclinical and clinical research.
| Phase | Units / Volume | Approx. Dose per Component | Duration | Notes |
|---|---|---|---|---|
| Start (tolerance) | 7.5 units / 0.075 mL | TB-500: 250 mcg · BPC-157: 250 mcg · KPV: 250 mcg · GHK-Cu: 1.25 mg | Weeks 1–2 | Reconstitute with 3.0 mL BAC water → ~26.7 mg/mL total. Once daily SubQ. |
| Ramp | 15 units / 0.15 mL | TB-500: 500 mcg · BPC-157: 500 mcg · KPV: 500 mcg · GHK-Cu: 2.5 mg | Weeks 3–4 | Advance after tolerance established. |
| Working dose | 22.5 units / 0.225 mL | TB-500: 750 mcg · BPC-157: 750 mcg · KPV: 750 mcg · GHK-Cu: 3.75 mg | Weeks 5–8 | Primary research dose. |
| Maintenance | 15 units / 0.15 mL | TB-500: 500 mcg · BPC-157: 500 mcg · KPV: 500 mcg · GHK-Cu: 2.5 mg | Weeks 9–12 | Extend to week 16 if desired. |
| Off cycle | — | — | 4–8 weeks | Rest before repeating cycle. |